IGF1R and myeloid sarcoma: Exosomal miRNA let-7i was found to increase in MS patients and to suppress T-reg cell induction by targeting insulin-like growth factor 1 receptor (IGF1R) and TGF-β receptor 1 (TGF-β R1), leading to autoimmune modulation [233].